Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19297783 | 0.90 | ACHE (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8637755 | 0.84 | CA1 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1134723 | 0.80 | CA1 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30250475 | 0.80 | CA1 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13066221 | 0.78 | CA1 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL473959 | 0.77 | CA12 (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30193796 | 0.77 | CA12 (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6449465 | 0.76 | CA1 (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7110300 | 0.76 | SLC6A4 (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL440122 | 0.74 | CA12 (0.62) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228514-A1 | BORON-CONTAINING ORGANIC COMPOUND AND APPLICATIONS THEREOF | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20240228514-A1 | BORON-CONTAINING ORGANIC COMPOUND AND APPLICATIONS THEREOF | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| CN-114621270-B | Condensed ring aromatic compound and application thereof in electroluminescent device | 清华大学 | 2024-04-12 | — | — | CN | disclosed |
| CN-114621269-B | Condensed ring aromatic compound and application thereof in electroluminescent device | 清华大学 | 2024-04-09 | — | — | CN | disclosed |
| CN-114621269-A | Fused aromatic compound and application thereof in electroluminescent device | 清华大学 | 2022-06-14 | — | — | CN | disclosed |
| CN-114621270-A | Fused aromatic compound and application thereof in electroluminescent device | 清华大学 | 2022-06-14 | — | — | CN | disclosed |
| CN-109563120-A | α -D-galactoside inhibitors of galectins | 格莱克特生物技术公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-107406478-A | ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS | 格莱克特生物技术公司 | 2017-11-28 | — | — | CN | disclosed |
| WO-2009136144-A1 | PURINE DERIVATIVES SUITABLE FOR THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISEASES | CHROMA THERAPEUTICS LTD (GB) | 2009-11-12 | — | — | WO | disclosed |
| CN-1061052-C | 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine | SCHERING AG (DE) | 2001-01-24 | — | — | CN | disclosed |
| CN-1133296-A | 11 beta-aromatic group-4-estraene and acid additive salt application in medicine | SCHERING AG (DE) | 1996-10-16 | — | — | CN | disclosed |
| EP-0404283-B1 | 11-Beta-aryl-4-estrene, method for its production and its use as a medicine | SCHERING AG (DE) | 1996-05-08 | — | — | EP | disclosed |
| US-5093507-A | 10β,11β-bridged steroids | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-03-03 | — | — | US | disclosed |
| CN-1048219-A | 11 beta-aryl-4-estrene pharmaceutical composition and process for preparing same | SCHERING AG (DE) | 1991-01-02 | — | — | CN | disclosed |
| EP-0404283-A2 | 11-Beta-aryl-4-estrene, method for its production and its use as a medicine | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-12-27 | — | — | EP | disclosed |
| US-4900751-A | 2-Pyridinyl-phenyl-sulphinyl-and-phenyl-thio-benzimidazoles having antiflammatory or gastic acid secretion inhibition activity | FISONS PLC (GB) | 1990-02-13 | — | — | US | disclosed |
| EP-0347370-A2 | 10-Beta, 11-beta-bridged steroids | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-12-20 | — | — | EP | disclosed |
| EP-0283504-A1 | COMPOUNDS | FISONS plc (GB) | 1988-09-28 | — | — | EP | disclosed |
| WO-1988002367-A1 | COMPOUNDS | FISONS PLC (GB) | 1988-04-07 | — | — | WO | disclosed |
| EP-0262845-A1 | Heterocyclic substituted azole derivatives | FISONS plc (GB) | 1988-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228514-A1 | BORON-CONTAINING ORGANIC COMPOUND AND APPLICATIONS THEREOF | BCL6, SLCO4C1, SLCO2B1 | CA12 1770/4885CA1 2775/4885CA2 1453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.